<DOC>
	<DOCNO>NCT02323594</DOCNO>
	<brief_summary>Grps 1 , 2 , 3 `` This study test performance ASV DCV pediatric chewable tablet . Grp # 4 The purpose group support marketing authorization DCV 90-mg tablet</brief_summary>
	<brief_title>A Bioequivalence Study Daclatasvir Tablets Bioavailability Studies Daclatasvir Asunaprevir</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>1 . Signed Written Informed Consent must obtain subject accordance requirement study center 's Institutional review Board ( IRB ) / Institutional Ethics Committee ( IEC ) 2 . Target Population : Healthy subject determine clinically significant deviation normal medical history , physical examination , ECGs , clinical laboratory determination . 3 . Age Reproductive Status : Males female , age 18 49 year , inclusive . Women childbearing potential ( WOCBP ) must negative serum pregnancy test within 24 hour prior start study drug must use acceptable method contraception 4 week prior study drug administration . Women must breastfeed . Males sexually active WOCBP must agree follow instruction method ( ) contraception duration treatment study drug female must still undergo pregnancy test described section . 1 . Medical History Concurrent Diseases : Any significant acute chronic medical illness . Current recent ( within 3 month study drug administration ) gastrointestinal disease could impact upon absorption study drug . Any major surgery within 4 week study drug administration . Any gastrointestinal surgery could impact upon absorption study drug ( appendectomy complication allow investigator 's discretion ) . Inability tolerate oral medication , smoker recent durg alcohol abuse Any sound medical , psychiatric , and/or social reason determine investigator . 2 . Physical Laboratory Test Findings : Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECG , clinical laboratory determination beyond consistent target population , positive urine screen drug , positive blood screen hepatitis C antibody , hepatitis B surface antigen , HIV1 , 2 antibody . 3 . Allergies Adverse Drug Reaction : History allergy DCV , ASV , Hepatitis C virus ( HCV ) NS3 protease inhibitor , HCV NS5A replication cofactor , related compound .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>